• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病中的皮质肌阵挛

Cortical myoclonus in Huntington's disease.

作者信息

Thompson P D, Bhatia K P, Brown P, Davis M B, Pires M, Quinn N P, Luthert P, Honovar M, O'Brien M D, Marsden C D

机构信息

University Department of Clinical Neurology, Guy's Hospital, London, England.

出版信息

Mov Disord. 1994 Nov;9(6):633-41. doi: 10.1002/mds.870090609.

DOI:10.1002/mds.870090609
PMID:7845404
Abstract

We describe three patients with Huntington's disease, from two families, in whom myoclonus was the predominant clinical feature. The diagnosis was confirmed at autopsy in two cases and by DNA analysis in all three. These patients all presented before the age of 30 years and were the offspring of affected fathers. Neurophysiological studies documented generalised and multifocal action myoclonus of cortical origin that was strikingly stimulus sensitive, without enlargement of the cortical somatosensory evoked potential. The myoclonus improved with piracetam therapy in one patient and a combination of sodium valproate and clonazepam in the other two. Cortical reflex myoclonus is a rare but disabling component of the complex movement disorder of Huntington's disease, which may lead to substantial diagnostic difficulties.

摘要

我们描述了来自两个家庭的三名亨廷顿舞蹈症患者,他们均以肌阵挛为主要临床特征。其中两例经尸检确诊,三例均经DNA分析确诊。这些患者均在30岁之前发病,且均为患病父亲的后代。神经生理学研究记录了起源于皮质的全身性和多灶性动作性肌阵挛,这种肌阵挛对刺激极为敏感,皮质体感诱发电位未增大。其中一名患者使用吡拉西坦治疗后肌阵挛有所改善,另外两名患者使用丙戊酸钠和氯硝西泮联合治疗后肌阵挛有所改善。皮质反射性肌阵挛是亨廷顿舞蹈症复杂运动障碍中一种罕见但致残的症状,可能会导致严重的诊断困难。

相似文献

1
Cortical myoclonus in Huntington's disease.亨廷顿舞蹈病中的皮质肌阵挛
Mov Disord. 1994 Nov;9(6):633-41. doi: 10.1002/mds.870090609.
2
Adult onset myoclonic Huntington's disease.成人起病型肌阵挛性亨廷顿病
Mov Disord. 1993 Apr;8(2):201-5. doi: 10.1002/mds.870080216.
3
Cortical Myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential.亨廷顿舞蹈病中的皮质肌阵挛与体感诱发电位增大有关。
Mov Disord. 1997 Nov;12(6):1046-51. doi: 10.1002/mds.870120633.
4
[Cortical reflex myoclonus in adult onset Huntington's disease].[成人起病型亨廷顿舞蹈病中的皮质反射性肌阵挛]
Rinsho Shinkeigaku. 2004 Sep;44(9):639-42.
5
Cortical myoclonus in childhood and juvenile onset Huntington's disease.儿童和青少年亨廷顿病的皮质肌阵挛。
Parkinsonism Relat Disord. 2012 Jul;18(6):794-7. doi: 10.1016/j.parkreldis.2012.03.011. Epub 2012 Apr 10.
6
Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations.帕金森病中的小振幅皮质肌阵挛:生理学与临床观察
Mov Disord. 2002 Jul;17(4):657-62. doi: 10.1002/mds.10177.
7
Cortical reflex myoclonus in Rett syndrome.雷特综合征中的皮质反射性肌阵挛。
Ann Neurol. 1998 Apr;43(4):472-9. doi: 10.1002/ana.410430410.
8
Effectiveness of piracetam in cortical myoclonus.吡拉西坦治疗皮质肌阵挛的疗效
Mov Disord. 1993;8(1):63-8. doi: 10.1002/mds.870080112.
9
Focal reflex myoclonus in corticobasal degeneration.皮质基底节变性中的局灶性反射性肌阵挛
Funct Neurol. 1991 Apr-Jun;6(2):165-70.
10
Myoclonus in corticobasal degeneration.皮质基底节变性中的肌阵挛
Clin Neurosci. 1995;3(4):203-8.

引用本文的文献

1
In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease.聚醚酰亚胺衍生的脂聚合物在亨廷顿舞蹈病神经元模型中沉默毒性蛋白的体外疗效
Pharmaceutics. 2025 May 30;17(6):726. doi: 10.3390/pharmaceutics17060726.
2
A Practical Guide for Clinical Approach to Patients With Huntington's Disease in Korea.韩国亨廷顿舞蹈病患者临床诊疗实用指南
J Mov Disord. 2024 Apr;17(2):138-149. doi: 10.14802/jmd.24040. Epub 2024 Mar 12.
3
State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.
用于减少亨廷顿舞蹈病舞蹈症状的最先进药理学方法。
Expert Opin Pharmacother. 2021 Jun;22(8):1015-1024. doi: 10.1080/14656566.2021.1876666. Epub 2021 Feb 8.
4
Waveform changes with the evolution of beta bursts in the human subthalamic nucleus.人类丘脑底核中β爆发的演变过程中的波形变化。
Clin Neurophysiol. 2020 Sep;131(9):2086-2099. doi: 10.1016/j.clinph.2020.05.035. Epub 2020 Jun 29.
5
International Guidelines for the Treatment of Huntington's Disease.亨廷顿舞蹈症治疗国际指南
Front Neurol. 2019 Jul 3;10:710. doi: 10.3389/fneur.2019.00710. eCollection 2019.
6
Huntington's Disease-Update on Treatments.亨廷顿病的治疗进展。
Curr Neurol Neurosci Rep. 2017 Apr;17(4):33. doi: 10.1007/s11910-017-0739-9.
7
Huntington's Disease and Striatal Signaling.亨廷顿病与纹状体信号转导
Front Neuroanat. 2011 Aug 23;5:55. doi: 10.3389/fnana.2011.00055. eCollection 2011.
8
Myoclonic disorders: a practical approach for diagnosis and treatment.肌阵挛性疾病:诊断与治疗的实用方法。
Ther Adv Neurol Disord. 2011 Jan;4(1):47-62. doi: 10.1177/1756285610395653.
9
Symptomatic treatment of Huntington disease.亨廷顿病的对症治疗。
Neurotherapeutics. 2008 Apr;5(2):181-97. doi: 10.1016/j.nurt.2008.01.008.
10
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.丙戊酸对8例亨廷顿舞蹈病患者肌阵挛性运动亢进的剂量依赖性改善:病例系列报告
BMC Neurol. 2006 Feb 28;6:11. doi: 10.1186/1471-2377-6-11.